In addition to these pharmacokinetic advantages, SDKP maintains selected bioactivities associated with cytoskeletal modulation and tissue remodeling in vitro, making it a useful probe for dissecting TB-500related pathways
Nosjean O, Ferro M, Coge F, Beauverger P, Henlin JM, Lefoulon F, Fauchere JL, Delagrange P, Canet E, Boutin JA (2000) Identification of the melatonin-binding site MT3 as the quinone reductase 2
It contributes to protein structure, sulfur metabolism and glutathione synthesis
Its natural origin, ability to cross the blood-brain barrier, and multi-modal mechanismsimpacting oxidative stress, mitochondrial dysfunction, and immune dysregulationmake it a promising candidate for integrative treatment approaches